Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma

von Bolomsky, Arnold, Heusschen, Roy, Schlangen, Karin, Stangelberger, Kathrin, Muller, Joséphine, Schreiner, Wolfgang, Zojer, Niklas, Caers, Jo, Ludwig, Heinz
Veröffentlicht in Haematologica (2018)

Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma

von Binsfeld, Marilène, Muller, Joséphine, Lamour, Virginie, Veirman, Kim De, Raeve, Hendrik De, Bellahcène, Akeila, Valckenborgh, Els Van, Baron, Frédéric, Beguin, Yves, Caers, Jo, Heusschen, Roy
Veröffentlicht in Oncotarget (2016)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

von Faict, Sylvia, Muller, Joséphine, De Veirman, Kim, De Bruyne, Elke, Maes, Ken, Vrancken, Louise, Heusschen, Roy, De Raeve, Hendrik, Schots, Rik, Vanderkerken, Karin, Caers, Jo, Menu, Eline
Veröffentlicht in Blood Cancer J (2018)

Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease

von Fransolet, Gilles, Ehx, Grégory, Somja, Joan, Delens, Loïc, Hannon, Muriel, Muller, Joséphine, Dubois, Sophie, Drion, Pierre, Caers, Jo, Humblet-Baron, Stéphanie, Delvenne, Philippe, Beguin, Yves, Conteduca, Giuseppina, Baron, Frédéric
Veröffentlicht in J Hematol Oncol (2016)

Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice

von Ehx, Grégory, Somja, Joan, Warnatz, Hans-Jörg, Ritacco, Caroline, Hannon, Muriel, Delens, Loïc, Fransolet, Gilles, Delvenne, Philippe, Muller, Joséphine, Beguin, Yves, Lehrach, Hans, Belle, Ludovic, Humblet-Baron, Stéphanie, Baron, Frédéric
Veröffentlicht in Front Immunol (2018)

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts

von Muller, Joséphine, Duray, Elodie, Lejeune, Margaux, Dubois, Sophie, Plougonven, Erwan, Léonard, Angélique, Storti, Paola, Giuliani, Nicola, Cohen-Solal, Martine, Hempel, Ute, Thijssen, Victor L., Beguin, Yves, Heusschen, Roy, Caers, Jo
Veröffentlicht in Cancers (Basel) (2019)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

von Heusschen, Roy, Muller, Joséphine, Binsfeld, Marilène, Marty, Caroline, Plougonven, Erwan, Dubois, Sophie, Mahli, Nadia, Moermans, Karen, Carmeliet, Geert, Léonard, Angélique, Baron, Frédéric, Beguin, Yves, Menu, Eline, Cohen-Solal, Martine, Caers, Jo
Veröffentlicht in Oncotarget (2016)

Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

von Muller, Joséphine, Bolomsky, Arnold, Dubois, Sophie, Duray, Elodie, Stangelberger, Kathrin, Plougonven, Erwan, Lejeune, Margaux, Léonard, Angélique, Marty, Caroline, Hempel, Ute, Baron, Frédéric, Beguin, Yves, Cohen-Solal, Martine, Ludwig, Heinz, Heusschen, Roy, Caers, Jo
Veröffentlicht in Haematologica (2018)